alpha-Tocopherol

DRUG5 trials

Sponsors

Consorci Mar Parc De Salut De Barcelona, University Health Network, Toronto, New York State Institute for Basic Research, Indonesia University, Dr Cipto Mangunkusumo General Hospital

Conditions

Alpha-tocopherolAlzheimer's DiseaseBeta Thalassemia Major AnemiaBreast NeoplasmsCardiac SurgeryDown SyndromeHemolysisOxidative Stress

Early Phase 1

Effect of Parenteral Alpha-Tocopherol in the Definitive Surgery of Tetralogy of Fallot

CompletedNCT07194304

Dr Cipto Mangunkusumo General HospitalAlpha-tocopherol, Cardiac Surgery, Tetralogy of Fallot (TOF)

Start: 2022-05-01End: 2025-06-01Updated: 2025-09-26

Phase 2

The Use of Pentoxifylline and Vitamin E in the Treatment of Chronic Breast Pain

TerminatedNCT00188669

University Health Network, TorontoBreast Neoplasms

Start: 2002-07-31Target: 48Updated: 2010-08-11

Phase 3

Multicenter Vitamin E Trial in Aging Persons With Down Syndrome

CompletedNCT01594346

New York State Institute for Basic ResearchAlzheimer's Disease, Down Syndrome

Start: 2000-09-30End: 2010-04-30Updated: 2012-05-09

Phase 4

REstoration with calcifediol of VItamin D deficiency in pulmonary Arterial Hypertension patients (REVIDAH study)

Not yet recruitingCTIS2025-521694-14-00

Consorci Mar Parc De Salut De Barcelonadrug- and toxin-induced PAH or associated to connective tissues disease, hereditary, Patients with diagnosis of Pulmonary Arterial Hypertension of the following types according to 2022 ERS/ESC guidelines: idiopathic

Target: 102Updated: 2025-09-02

Unknown Phase

The Effect of Alpha-tocopherol in Hemolysis and Oxidative Stress Marker on the Red Cell Membrane Beta-thalassemia Major

CompletedNCT03948737

Indonesia UniversityBeta Thalassemia Major Anemia, Hemolysis, Oxidative Stress

Start: 2016-12-30End: 2017-08-01Updated: 2019-05-14